Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health improvement network (THIN) data

May-13

Men's Health Pharmacoepidemiology Urology

AUTHORS : Zalmai Hakimi PharmD MSc, Astellas Pharma Global, Development, Sylviusweg 62, PO Box 344, Leiden, Netherlands – Email: Zalmai.Hakimi@astellas.com

JOURNAL : Value in Health

REFERENCE: 16(3):A184

DOI : 10.1016/j.jval.2013.03.925

Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health improvement network (THIN) data

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study